BIO-TECHNE LTD
Get an alert when BIO-TECHNE LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2026-09-26 (in 4mo)
Last made up 2025-09-12
Watchouts
None on the register
Cash
£4M
-70.8% vs 2024
Net assets
£124M
-22% vs 2024
Employees
168
-1.2% vs 2024
Profit before tax
£4M
-84.9% vs 2024
Name history
Renamed 3 times since incorporation
- BIO-TECHNE LTD 2016-02-17 → present
- R & D SYSTEMS EUROPE LTD. 1993-09-06 → 2016-02-17
- BRITISH BIO-TECHNOLOGY PRODUCTS LIMITED 1991-10-28 → 1993-09-06
- LEADEROD LIMITED 1990-04-06 → 1991-10-28
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-06-30
| Metric | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Turnover | £53,121,000 | £38,107,000 | |
| Operating profit | £3,340,000 | £3,319,000 | |
| Profit before tax | £29,237,000 | £4,425,000 | |
| Net profit | £28,459,000 | £3,588,000 | |
| Cash | £13,607,000 | £3,976,000 | |
| Total assets less current liabilities | £159,940,000 | £125,366,000 | |
| Net assets | £158,977,000 | £124,017,000 | |
| Equity | £158,977,000 | £124,017,000 | |
| Average employees | 170 | 168 | |
| Wages | £11,278,000 | £12,331,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating margin | 6.3% | 8.7% | |
| Net margin | 53.6% | 9.4% | |
| Return on capital employed | 2.1% | 2.6% | |
| Gearing (liabilities / total assets) | 5.4% | 6.9% | |
| Current ratio | 7.28x | 2.67x | |
| Interest cover | 303.64x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Group structure
- BIO-TECHNE LTD · parent
- Bio-Techne GmbH 100%
- Bio-Techne AG 100%
- Tocris Cookson Ltd 100%
- Bio-Techne S.r.l 100%
- Bio-Techne R&D Systems s.r.o. 100%
- Bio-Techne R&D Systems S.L 100%
- Bio-Techne R&D Systems Kft. 100%
- Bio-Techne sp. z o.o. 100%
- Bio-Techne SAS 100%
Significant events
- “Revenue from operations decreased 28% compared with the prior year. This was a continued effect of the strategic decision by the Bio-Techne group to close the UK distribution hub in April 2024.”
- “The transition begun in FY22 was further extended in FY24 with the consolidation of distribution activities in Ireland.”
- “Management have discontinued operations with Russia since the conflict between Russia and Ukraine began. The discontinuation with Russia has not had a materially impact on the operative activities of the Company.”
- “During the year £142,000 was recognised as an expense in the profit and loss account in respect of operating leases (2024: £307,000). There is no ongoing obligation following the company's termination of the distribution in the UK.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WATSON, Gina Sarah | Secretary | 2016-12-22 | — | — |
| BOHNEN, Shane | Director | 2023-03-01 | Dec 1974 | American |
| GATHERUM, Sarah Jane | Director | 2022-08-01 | Dec 1967 | British |
| SCHUESSLER, Peter, Dr | Director | 2024-10-01 | Aug 1966 | German |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRIGHT, Ruth | Secretary | 2004-08-31 | 2016-12-22 |
| FINCH, William John Hugh | Secretary | 1993-07-30 | 1997-03-03 |
| GREEN, Roberta Susan | Secretary | 1997-03-03 | 2004-08-31 |
| RICHARDS, Brian Mansel, Sir | Secretary | — | 1991-09-13 |
| WEIR, Anthony John | Secretary | 1991-09-13 | 1993-07-30 |
| ALLEN, Gerald John, Dr | Director | 1992-09-29 | 1997-03-03 |
| BACKES, Kathleen | Director | 2003-11-14 | 2016-01-13 |
| BRIGHT, Ruth | Director | 2000-09-18 | 2022-08-01 |
| CARLSON, Robert Walter | Director | 1997-03-03 | 2003-11-14 |
| DETWILER, Thomas Crump | Director | 1994-09-14 | 2000-07-07 |
| FINCH, William John Hugh | Director | 1992-09-29 | 1997-03-03 |
| FURLOW, Brenda Swierenga | Director | 2016-01-13 | 2023-03-01 |
| GORDON, John Laurie, Dr | Director | 1991-09-13 | 1993-07-30 |
| GREEN, Roberta Susan | Director | 1997-03-03 | 2005-07-01 |
| HIPPEL, James | Director | 2016-01-13 | 2016-06-16 |
| KUMMETH, Charles Robert | Director | 2013-07-24 | 2017-09-01 |
| LUCAS, Roger, Doctor | Director | 1994-02-16 | 1995-06-30 |
| MARTIN, Anthony Francis, Doctor | Director | 1991-09-13 | 1993-03-12 |
| MCCULLAGH, Keith Graham, Dr | Director | 1992-10-19 | 1993-07-30 |
| MELSEN, Gregory J | Director | 2005-06-21 | 2014-01-31 |
| NOBLE, James Julian | Director | 1991-09-13 | 1993-07-30 |
| OLAND, Thomas E | Director | 1995-06-30 | 2012-11-30 |
| RICHARDS, Brian Mansel, Sir | Director | — | 1991-09-13 |
| ROWLING, Richard Robert | Director | 1997-03-03 | 1997-05-09 |
| STAPLETON, Gary Michael | Director | 2016-06-16 | 2023-03-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bio-Techne Corporation | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 166 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-07 | AA | accounts | Accounts with accounts type full | |
| 2025-09-18 | AA | accounts | Accounts with accounts type full | |
| 2025-09-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-11 | CH01 | officers | Change person director company with change date | |
| 2024-10-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-08 | AA | accounts | Accounts with accounts type full | |
| 2023-09-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-14 | AA | accounts | Accounts with accounts type full | |
| 2023-03-01 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-01 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-02 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-02 | TM01 | officers | Termination director company with name termination date | |
| 2022-03-28 | AA | accounts | Accounts with accounts type full | |
| 2021-09-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-07-29 | AA | accounts | Accounts with accounts type full | |
| 2020-09-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-09-07 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
-
Turnover
-28.3%
£53,121,000 £38,107,000
-
Cash
-70.8%
£13,607,000 £3,976,000
-
Net assets
-22%
£158,977,000 £124,017,000
-
Employees
-1.2%
170 168
-
Operating profit
-0.6%
£3,340,000 £3,319,000
-
Profit before tax
-84.9%
£29,237,000 £4,425,000
-
Wages
+9.3%
£11,278,000 £12,331,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers